Uri Weinberg, Chief Science Officer at NovoCure Ltd (NVCR), sold 11,300 shares at $189.65 ($2.1M) on 2021-05-10, disclosed to the SEC on 2021-05-12.
Open-market sale of $2.1M NVCR by Chief Science Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $189.65 | 1,804 | $342K | 16.0% |
| 2 | $189.65 | 1,804 | $342K | 16.0% |
| 3 | $189.65 | 3,846 | $729K | 34.0% |
| 4 | $189.65 | 3,846 | $729K | 34.0% |
| Total | $189.65 avg | 11,300 | $2.1M | 100% |
| Filing → |
| NVCR | SELL | 2025-03-04 | $5K | — | Filing → |
| NVCR | SELL | 2025-03-03 | $168K | — | Filing → |
| NVCR | SELL | 2023-01-09 | $946K | — | Filing → |